866-234-0222 
Real-Time Treatment for Emerging Adults and their Families
Blog
A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders
Francis X. Brennan, PhD; Kathryn R. Gardner, MS; Jay Lombard, DO; Roy H. Perlis, MD, MSc; Maurizio Fava, MD; Herbert…
A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders
Francis X. Brennan, PhD; Kathryn R. Gardner, MS; Jay Lombard, DO; Roy H. Perlis, MD, MSc; Maurizio Fava, MD; Herbert…
Correlation of Clinical Response With Homocysteine Reduction During Therapy With Reduced B Vitamins in Patients With MDD Who Are Positive for MTHFR C677T or A1298C Polymorphism: A Randomized, Double-Blind, Placebo-Controlled Study
Correlation of Clinical Response With Homocysteine Reduction During Therapy With Reduced B Vitamins in Patients With MDD Who Are Positive for MTHFR C677T or A1298C Polymorphism: A Randomized, Double-Blind, Placebo-Controlled Study
Read MoreThe Re-emerging Role of Therapeutic Neuromodulation
Philip G. Janicak, MD, Sheila M. Dowd, PhD, Jeffrey T. Rado, MD, Mary Jane Welch, DNP, APRN, BC, CIP Current…
The Re-emerging Role of Therapeutic Neuromodulation
Philip G. Janicak, MD, Sheila M. Dowd, PhD, Jeffrey T. Rado, MD, Mary Jane Welch, DNP, APRN, BC, CIP Current…
Neuropsychiatry and quantitative EEG in the 21st Century
Robert W Thatcher Neuropsychiatry Vol. 1, No. 5, Pages 495-514 , DOI 10.2217/npy.11.45
Neuropsychiatry and quantitative EEG in the 21st Century
Robert W Thatcher Neuropsychiatry Vol. 1, No. 5, Pages 495-514 , DOI 10.2217/npy.11.45
What Is Neurofeedback:: An Update
D. Corydon Hammond Physical Medicine & Rehabilitation, University of Utah School of Medicine, Salt Lake City, Utah, USA Journal of…
What Is Neurofeedback:: An Update
D. Corydon Hammond Physical Medicine & Rehabilitation, University of Utah School of Medicine, Salt Lake City, Utah, USA Journal of…
Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation for Acute Treatment of Medication-Resistant Depression
Mark S. George, M.D., Robert M. Post, M.D. American Journal of Psychiatry, 168:356-364, April 2011 doi: 10.1176/appi.ajp.2010.10060864, © 2011 American…
Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation for Acute Treatment of Medication-Resistant Depression
Mark S. George, M.D., Robert M. Post, M.D. American Journal of Psychiatry, 168:356-364, April 2011 doi: 10.1176/appi.ajp.2010.10060864, © 2011 American…
A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation (TMS) for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period
Dunner, D.L., et als. (2014) psychiatrist.com, J Clin Psychiatry 75:12, December 2014
A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation (TMS) for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period
Dunner, D.L., et als. (2014) psychiatrist.com, J Clin Psychiatry 75:12, December 2014
Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial
Yechiel Levkovitz1, Moshe Isserles2, Frank Padberg3, Sarah H. Lisanby4, Alexander Bystritsky5, Guohua Xia6, Aron Tendler7, Zafiris J. Daskalakis8, Jaron L….
Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial
Yechiel Levkovitz1, Moshe Isserles2, Frank Padberg3, Sarah H. Lisanby4, Alexander Bystritsky5, Guohua Xia6, Aron Tendler7, Zafiris J. Daskalakis8, Jaron L….
Effectiveness of Deep Transcranial Magnetic Stimulation Combined with a Brief Exposure Procedure in Post-Traumatic Stress Disorder A Pilot Study
Moshe Isserles, Arieh Y. Shalev, Yiftach Roth, Tuvia Peri, Ilan Kutz, Elad Zlotnick, Abraham Zangen Brain Stimulation 6 (2013) 377e383
Effectiveness of Deep Transcranial Magnetic Stimulation Combined with a Brief Exposure Procedure in Post-Traumatic Stress Disorder A Pilot Study
Moshe Isserles, Arieh Y. Shalev, Yiftach Roth, Tuvia Peri, Ilan Kutz, Elad Zlotnick, Abraham Zangen Brain Stimulation 6 (2013) 377e383
Genomind White Paper, The Science Behind the Genecept Assay™
Genomind White Paper, The Science Behind the Genecept Assay™
Genomind White Paper, The Science Behind the Genecept Assay™
Genomind White Paper, The Science Behind the Genecept Assay™
L-Methylfolate: A Vitamin for Your Monomamines
Stephen M. Stahl, M.D. Ph.D. J Clin Psychiatry, 69:9, September 2008
L-Methylfolate: A Vitamin for Your Monomamines
Stephen M. Stahl, M.D. Ph.D. J Clin Psychiatry, 69:9, September 2008
L-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials
George I. Papakostas, M.D., Richard C. Shelton, M.D., John M. Zajecka, M.D., Bijan Etemad, M.D., Karl Rickels, M.D., Alisabet Clain,…
L-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials
George I. Papakostas, M.D., Richard C. Shelton, M.D., John M. Zajecka, M.D., Bijan Etemad, M.D., Karl Rickels, M.D., Alisabet Clain,…
Risk of suicide after a concussion
Michael Fralick MD BScH, Deva Thiruchelvam MSc, Homer C. Tien MD MSc, Donald A. Redelmeier MD MS(HSR) CMAJ Podcasts: author…
Risk of suicide after a concussion
Michael Fralick MD BScH, Deva Thiruchelvam MSc, Homer C. Tien MD MSc, Donald A. Redelmeier MD MS(HSR) CMAJ Podcasts: author…
Long-Term Efficacy, Safety, and Tolerability of l-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors: A 12-Month, Open-Label Study Following a Placebo-Controlled Acute Study
John M. Zajecka, MD,; Maurizio Fava, MD; Richard C. Shelton, MD; Lori W. Barrentine, MS, PA-C; Page Young, BSd; and…
Long-Term Efficacy, Safety, and Tolerability of l-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors: A 12-Month, Open-Label Study Following a Placebo-Controlled Acute Study
John M. Zajecka, MD,; Maurizio Fava, MD; Richard C. Shelton, MD; Lori W. Barrentine, MS, PA-C; Page Young, BSd; and…
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Jerome Sarris, Ph.D., M.H.Sc., Jenifer Murphy, Ph.D., David Mischoulon, M.D., Ph.D., George I. Papakostas, M.D., Maurizio Fava, M.D., Michael Berk,…
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Jerome Sarris, Ph.D., M.H.Sc., Jenifer Murphy, Ph.D., David Mischoulon, M.D., Ph.D., George I. Papakostas, M.D., Maurizio Fava, M.D., Michael Berk,…
Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder
RJT Mocking, I Harmsen, J Assies, MWJ Koeter, HG Ruhé and AH Schene, Translational Psychiatry (2016) 6, e756; doi:10.1038/tp.2016.29; published…
Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder
RJT Mocking, I Harmsen, J Assies, MWJ Koeter, HG Ruhé and AH Schene, Translational Psychiatry (2016) 6, e756; doi:10.1038/tp.2016.29; published…
Anxiety About Antidepressants
Roy H. Perlis , M.D., M.Sc. Am J Psychiatry 175:6, June 2018, pp. 500 – 501
Anxiety About Antidepressants
Roy H. Perlis , M.D., M.Sc. Am J Psychiatry 175:6, June 2018, pp. 500 – 501
The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?
Charles B. Nemeroff, M.D., Ph.D. Am J Psychiatry 177:8, August 2020
The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?
Charles B. Nemeroff, M.D., Ph.D. Am J Psychiatry 177:8, August 2020
Whither TMS: A One-Trick Pony or the Beginning of a Neuroscientific Revolution?
By Mark S. George, M.D., Am J Psychiatry 176:11, November 2019, pgs. 904 – 910
Whither TMS: A One-Trick Pony or the Beginning of a Neuroscientific Revolution?
By Mark S. George, M.D., Am J Psychiatry 176:11, November 2019, pgs. 904 – 910
Take the Next Step
Yellowbrick collaborates with adolescents and emerging adults, ages 16-30's, their families and participating professionals toward the development and implementation of a strategic “Life Plan.” An integrative, multi-specialty consultation clarifies strengths, limitations, and risks, and defines motivations, goals and choices.
866-234-0222